AIM ImmunoTech Files Three Provisional Patent Applications Surrounding Ampligen(R) for Use Against the SARS-like Wuhan 2019 Novel Coronavirus
- Written by: ACN Newswire - Press Releases
Read more //?#
.
-for-use-against-the-sars-like-wuhan-2019-novel-coronavirus&media=https://businessdailymedia.com/http://www.acnnewswire.com/images/company/AIMImmunoTech.jpg&description=AIM%20ImmunoTech%20Files%20Three%20Provisional%20Patent%20Applications%20Surrounding%20Ampligen(R)%20for%20Use%20Against%20the%20SARS-like%20Wuhan%202019%20Novel%20Coronavirus "Pin It")
Australian businesses lean into global strategic partnerships (GCCs) for next wave of outsourcing
The Australian corporate landscape is undergoing a fundamental transformation in how it sources talent and innovation. While businesses have traditi...
The New Pressure Gap Crushing Small Businesses
Starting any business and making it prosper is a major undertaking. Part of the challenge is managing the uncertainty, but the financial pressures o...
Click Frenzy returns with a free EOFY sale event for retailers this month
New owners Gabby and Hezi Leibovich bring back Australia’s leading ecommerce sales event with Australia Post as Major Sponsor Click Frenzy is ...
The 95 Per Cent Failure Rate Is Not An AI Problem
Most Australian SMEs I speak with are already having a go at AI. Some are running formal pilots, others have a team member quietly experimenting o...
New AR tech helping to solve field service skills crisis
AI-enabled augmented reality (AR) smart glasses are emerging as a new practical solution to fill a shortage of field service technicians maintaini...
For Midsize Companies, Global Payroll Systems Matter More to Business-Security Than You Think
When a midsize company expands across borders, its payroll operation becomes exponentially more complex. These organisations typically face a new ...